Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response [IMMUNOTHERAPY AND VACCINES] - Khong, H., Volmari, A., Sharma, M., Dai, Z., Imo, C. S., Hailemichael, Y., Singh, M., Moore, D. T., Xiao, Z., Huang, X.-f., Horvath, T. D., Hawke, D. H., Overwijk, W. W. (The American Association of Immunologists (AAI), 2018)
6253132